A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets

Recruiting

Phase 1

Divalproex SodiumA Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets

Sponsor:

Vince & Associates Clinical Research, Inc.

Code:

NCT01898676

Conditions

Epilepsy

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Divalproex Sodium Extended-release 250mg

DEPAKOTE 250mg

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-15. This information was provided to ClinicalTrials.gov by Vince & Associates Clinical Research, Inc. on 2013-07-12.